guglsky.blogg.se

1. Eating disorder treatment centers rate it facebook manual#
2. Eating disorder treatment centers rate it facebook full#

Eating disorder treatment centers rate it facebook full#

Characteristics of the full sample at intake have been described elsewhere ( Herzog et al. Exclusion criteria were terminal illness or organic brain syndrome. After reclassification into DSM-IV criteria ( American Psychiatric Association, 1994), the sample included 51 women with AN-restricting type (ANR), 85 women with AN-binge/purge type (ANBP), and 110 women with BN.įor study inclusion, participants were required to be female, English-speaking, at least 12 years of age, reside within 200 miles of the study site, and meet full criteria for AN or BN. Two hundred and twenty-five women originally agreed to participate in the study, and in 1991, 21 additional participants with AN were recruited through Boston-area clinics, increasing the sample size to 246 women.

Eating disorder treatment centers rate it facebook manual#

Likewise, we expected that women who received antidepressants would be more likely to recover from MDD, even if their ED did not significantly improve.įive hundred and fifty-four women who sought treatment at Massachusetts General Hospital and other treatment centers in the Boston area between 19 were screened to determine whether they met criteria for AN or BN set forth in the 3 rd Revised Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R American Psychiatric Association, 1987). In this study we address the following questions about MDD: (a) What is the course of MDD? (b) What variables are associated with recovery from and relapse to MDD? and (c) What types of antidepressant medications do women with EDs receive for MDD and are these treatments adequate by current standards? We hypothesized that the course of MDD would be longer if there was no recovery from ED. By a median of 9 years of follow-up, 11 women had died ( Keel et al. Depression severity was associated with increased risk for attempted suicide in AN participants ( Franko et al. We have previously examined psychiatric comorbidity and found high rates of MDD in this sample ( Herzog et al. In 1987 we initiated a prospective longitudinal study of treatment-seeking women with AN and BN to map the course and outcome of EDs. In view of the high rates of suicide and treatment resistance in individuals with comorbid MDD and ED, characterizing the course of MDD and identifying predictors of MDD recovery and relapse in individuals with EDs are important avenues for research.

Moreover, antidepressant treatment does not result in improvement in depressive symptomatology in anorexia nervosa (AN) treatment trials ( Attia et al.

1991 Fluoxetine Bulimia Nervosa Collaborative Study Group, 1992 Goldbloom & Olmsted, 1993 Beumont et al. Although fluoxetine has been approved to treat bulimia nervosa (BN), the drug has shown mixed efficacy in reducing MDD in this group ( Pope et al. 2009).ĭespite the overlap between EDs and depression, FDA-approved antidepressants have not shown promise in alleviating depression in patients with EDs. 2009) and suicide-related mortality ( Crow et al. 2007), including high rates of suicide attempts ( Franko et al. 2008) the American Psychiatric Association has reported that lifetime rates of MDD in individuals with EDs range between 50% and 75% ( American Psychiatric Association Workgroup on Eating Disorders, 2006) and MDD comorbid with EDs has been associated with worse ED outcome ( Lowe et al. 1992 Fichter & Quadflieg, 2004 Kaye et al. Multiple studies indicate that MDD is the most common comorbid diagnosis in patients with EDs ( Herzog et al. Eating disorders (EDs) have high rates of comorbidity with other mental illnesses, especially major depressive disorder (MDD).